The roots of innovation – Can we afford to turn away from natural product drug discovery research?
European Biopharmaceutical Review, January 2011, p.52 Kai Lamottke at Bicoll GmbH, Christophe Ripoll at Naturalpha and Robert Walczak at Genfit SA ask if the biotech industry can afford to turn away from natural product drug discovery research. One of the …